Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Back

EHRA Premium Access

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Session: Pathophysiology of atrial fibrillation and beyond I

Topic: Pathophysiology and Mechanisms

Speaker: Doctor A. Khashaba (Birmingham, GB)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Doctor Alya Khashaba

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Impact of atrial fibrillation pattern on left atrial appendage closure: insights from the prospective LAARGE registry

Speaker: Doctor S. Kany (Hamburg, DE)

Sacubitril/valsartan therapy and supraventricular arrhythmias detected through remote monitoring in heart failure patients

Speaker: Associate Professor F. Guerra (Ancona, IT)

RNA-seq profiling of the atrial transcriptome reveals gender-specific patterns and interactions with atrial fibrillation and heart failure

Speaker: Mr D. Balamurali (Maastricht, NL)

Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive fibrosis

Speaker: Mr L. Hopman (Amsterdam, NL)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Speaker: Doctor A. Papazoglou (Athens, GR)

Access the full session

Pathophysiology of atrial fibrillation and beyond I

Speakers: Doctor A. Khashaba, Doctor S. Kany, Associate Professor F. Guerra, Mr D. Balamurali, Mr L. Hopman...

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources